Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.

about

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.

Item

http://www.wikidata.org/entity/Q40182576

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.

@en

type

Item

label

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.

@en

prefLabel

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.

@en

P1476

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.

@en

P2093

Kook In Park

http://www.w3.org/2001/XMLSchema#string

Min Soo Park

http://www.w3.org/2001/XMLSchema#string

P2860

Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin

Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis

The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

Serum cystatin C as an endogenous marker of the renal function--a review.

Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions.

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Cystatin C: an improved estimator of glomerular filtration rate?

Clinical evaluation of serum cystatin C and creatinine in patients with chronic kidney disease: a meta-analysis.

P304

421-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3345/KJP.2015.58.11.421

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26692877

http://www.w3.org/2001/XMLSchema#string

P932

4675922

http://www.w3.org/2001/XMLSchema#string